Cargando…
Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery
In 2021, mRNA vaccines against COVID-19 were approved by the Food and Drug Administration. mRNA vaccines are important for preventing severe COVID-19 and returning to normal life. The development of RNA-delivery technology, including mRNA vaccines, has been investigated worldwide for ~30 years. Lipi...
Autores principales: | Maeki, Masatoshi, Uno, Shuya, Niwa, Ayuka, Okada, Yuto, Tokeshi, Manabu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851889/ https://www.ncbi.nlm.nih.gov/pubmed/35183654 http://dx.doi.org/10.1016/j.jconrel.2022.02.017 |
Ejemplares similares
-
Three-dimensional, symmetrically assembled microfluidic device for lipid nanoparticle production
por: Kimura, Niko, et al.
Publicado: (2021) -
Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers
por: Maeki, Masatoshi, et al.
Publicado: (2017) -
Effect of Organic
Solvents on a Production of PLGA-Based
Drug-Loaded Nanoparticles Using a Microfluidic Device
por: Bao, Yi, et al.
Publicado: (2022) -
Development of the iLiNP Device: Fine Tuning the Lipid
Nanoparticle Size within 10 nm for Drug Delivery
por: Kimura, Niko, et al.
Publicado: (2018) -
Advances in Microfluidic Paper-Based Analytical Devices for Food and Water Analysis
por: Busa, Lori Shayne Alamo, et al.
Publicado: (2016)